电化学生物传感器检测尿路感染的研究进展
本文综述了电化学生物传感器在尿路感染检测中的发展,涵盖靶向病原体(如细菌16S rRNA的DNA传感器阵列,约1小时内鉴定,敏感性约89-100%,特异性高达100%)和宿主反应(如乳铁蛋白、前列腺素E2)两类平台,并讨论了整合微流控进行快速药敏试验、临床验证及转化挑战。
要点
- DNA传感器阵列靶向16S rRNA可在约1小时内鉴定尿路病原体,敏感性约89-100%,特异性高达100%。
- 电化学平台可定量尿宿主标志物(如乳铁蛋白、前列腺素E2),分钟级区分UTI阳性与阴性样本。
- 整合芯片系统可快速进行表型药敏试验和最低抑菌浓度测定,缩短靶向治疗时间。
核心结论
- 电化学生物传感器有望克服传统尿路感染诊断依赖慢速培养和低特异性试纸的局限,实现快速、敏感、可及即时检测的结果。
研究设计与样本
- 叙述性综述,综合了靶向病原体和宿主反应的电化学生物传感器在尿路感染检测中的发展。
主要发现
- 靶向细菌16S rRNA的DNA传感器阵列可在约1小时内对常见及混合尿路病原体进行种特异性鉴定,临床尿样中报道敏感性约89-100%,特异性高达100%。
- 整合芯片和阵列系统可快速进行表型抗菌药物敏感性试验和最低抑菌浓度测定,显著缩短至靶向治疗的时间。
- 基于阻抗的适配体传感器、夹心免疫传感器及电流体电容或侧流电化学格式可定量尿乳铁蛋白和前列腺素E2,在少量未处理尿液中无标记操作,数分钟内区分UTI阳性与阴性样本。
- 新兴设计通过噬菌体识别、纳米结构电极、分子印迹和DNAzyme扩增靶向特定病原体(如肺炎克雷伯菌、屎肠球菌)或活菌。
关键数值与推荐
- DNA传感器阵列靶向细菌16S rRNA:约1小时内种特异性鉴定,临床尿样敏感性约89-100%,特异性高达100%。
临床怎么用
- 电化学生物传感器可用于尿路感染的快速病原体鉴定和药敏试验,指导靶向治疗。
- 宿主标志物电化学平台可在数分钟内无标记检测少量未处理尿液,辅助判断UTI阳性与阴性。
局限性
- 转化挑战包括基质效应、多重检测需求和家庭或即时检测的整合问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Electrochemical biosensors have emerged as promising tools to address major limitations of conventional urinary tract infection (UTI) diagnosis, which depends on slow culture and low-specificity dipsticks. By transducing specific biorecognition events into electrical signals, these platforms can deliver rapid, sensitive, and potentially point of care results directly from urine. This narrative review synthesizes developments in pathogen directed and host response based electrochemical biosensors for UTI detection. DNA biosensor arrays targeting bacterial 16S rRNA enable species specific identification of common and polymicrobial uropathogens within ∼1 h, with reported sensitivities around 89-100% and specificities up to 100% in clinical urine samples. Integrated lab on chip and array systems further extend this approach to rapid phenotypic antimicrobial susceptibility testing and minimum inhibitory concentration determination, substantially shortening time to targeted therapy. In parallel, several platforms quantify urinary host biomarkers, such as lactoferrin and prostaglandin E2, as objective measures of pyuria and inflammatory response. These include impedance based aptasensors, sandwich immunosensors, and novel electrofluidic capacitor or lateral flow electrochemical formats that operate label free in small volumes of unprocessed urine and can discriminate UTI positive from UTI negative samples within minutes. Emerging designs also target specific pathogens (e.g., Klebsiella pneumoniae, Enterococcus faecium) or live bacteria via phage recognition, nanostructured electrodes, molecular imprinting, and DNAzyme based amplification. The review highlights analytical performance, clinical validation, and translational challenges including matrix effects, multiplexing needs, and integration for home or point of care use framing electrochemical biosensors as key candidates for next generation, rapid, and more informative UTI diagnostics.
引用
- Abuhassan Q, Al-Nabulsi JI, Younis SMD, et al. Electrochemical biosensors for the detection of urinary tract infections. Clin Chim Acta. 2026. PMID: 42250677. doi:10.1016/j.cca.2026.121144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。